Asterios Karagiannis
About
Asterios Karagiannis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Asterios Karagiannis has authored 215 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Endocrinology, Diabetes and Metabolism, 81 papers in Surgery and 71 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Asterios Karagiannis's work include Lipoproteins and Cardiovascular Health (55 papers), Diabetes Treatment and Management (35 papers) and Cardiovascular Health and Disease Prevention (32 papers). Asterios Karagiannis is often cited by papers focused on Lipoproteins and Cardiovascular Health (55 papers), Diabetes Treatment and Management (35 papers) and Cardiovascular Health and Disease Prevention (32 papers). Asterios Karagiannis collaborates with scholars based in Greece, United Kingdom and United States. Asterios Karagiannis's co-authors include Vasilios G. Athyros, Κωνσταντίνος Τζιόμαλος, Dimitri P. Mikhailidis, Panagiotis Anagnostis, Niki Katsiki, Anna I. Kakafika, Dimitri P. Mikhailidis, Michael Doumas, Κonstantinos Imprialos and Konstantinos Stavropoulos and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Asterios Karagiannis
211 papers receiving 6.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Asterios Karagiannis Greece | 43 | 2.6k | 1.8k | 1.8k | 1.6k | 889 | 215 | 6.6k | ||
| Κωνσταντίνος Τζιόμαλος Greece | 45 | 2.4k 0.9× | 2.3k 1.3× | 1.7k 0.9× | 1.5k 1.0× | 873 1.0× | 308 | 7.7k | ||
| Evangelos Liberopoulos Greece | 42 | 2.2k 0.8× | 1.3k 0.7× | 2.3k 1.3× | 1.1k 0.7× | 937 1.1× | 292 | 6.2k | ||
| Niki Katsiki Greece | 48 | 2.6k 1.0× | 1.9k 1.0× | 2.0k 1.1× | 1.6k 1.0× | 1.7k 1.9× | 299 | 8.6k | ||
| Hubert Scharnagl Austria | 49 | 1.8k 0.7× | 1.3k 0.7× | 2.6k 1.4× | 1.6k 1.0× | 1.4k 1.6× | 265 | 7.4k | ||
| Luis E. Simental‐Mendía Mexico | 40 | 2.1k 0.8× | 1.6k 0.9× | 1.1k 0.6× | 1.0k 0.7× | 1.1k 1.3× | 160 | 6.6k | ||
| Chul Woo Ahn South Korea | 46 | 3.0k 1.1× | 2.0k 1.1× | 1.5k 0.8× | 1.6k 1.1× | 1.9k 2.2× | 303 | 8.5k | ||
| Wayne Huey‐Herng Sheu Taiwan | 44 | 3.0k 1.1× | 1.3k 0.7× | 1.4k 0.8× | 1.5k 1.0× | 1.8k 2.0× | 372 | 8.1k | ||
| Yoshihiro Kokubo Japan | 50 | 1.6k 0.6× | 1.2k 0.7× | 1.2k 0.6× | 2.3k 1.5× | 1.2k 1.4× | 247 | 8.2k | ||
| Byung‐Wan Lee South Korea | 42 | 2.6k 1.0× | 2.6k 1.4× | 1.3k 0.7× | 929 0.6× | 1.5k 1.7× | 278 | 6.9k | ||
| Ian F. Godsland United Kingdom | 52 | 4.3k 1.6× | 1.3k 0.7× | 1.5k 0.8× | 2.0k 1.3× | 1.4k 1.6× | 176 | 9.3k |
Countries citing papers authored by Asterios Karagiannis
Since
Specialization
Citations
This map shows the geographic impact of Asterios Karagiannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asterios Karagiannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asterios Karagiannis more than expected).
Fields of papers citing papers by Asterios Karagiannis
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Asterios Karagiannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asterios Karagiannis. The network helps show where Asterios Karagiannis may publish in the future.
Co-authorship network of co-authors of Asterios Karagiannis
This figure shows the co-authorship network connecting the top 25 collaborators of Asterios Karagiannis. A scholar is included among the top collaborators of Asterios Karagiannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asterios Karagiannis. Asterios Karagiannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Katsimardou, Alexandra, Dimitrios Patoulias, Ioanna Zografou, et al.. (2023). The Associations between Kidney Function and Sexual Dysfunction among Males and Females with Type 2 Diabetes Mellitus. Medicina. 59(5). 969–969.
2.
Patoulias, Dimitrios, Christodoulos Papadopoulos, Asterios Karagiannis, & Michael Doumas. (2022). Meta-Analysis Assessing the Impact of Previous Heart Failure and Chronic Kidney Disease on the Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor Agonists. The American Journal of Cardiology. 167. 165–167.
3.
Patoulias, Dimitrios, Christodoulos Papadopoulos, George Kassimis, et al.. (2022). Effect of sodium-glucose co-transporter-2 inhibitors on arterial stiffness: A systematic review and meta-analysis of randomized controlled trials. Vascular Medicine. 27(5). 433–439.
4.
Patoulias, Dimitrios, Christodoulos Papadopoulos, George Kassimis, et al.. (2021). Meta-Analysis Addressing the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Flow-Mediated Dilation in Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology. 165. 133–135.
5.
Zografou, Ioanna, Christos Sampanis, Vasilios G. Athyros, et al.. (2021). Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers. HORMONES. 21(1). 91–101.
6.
Patoulias, Dimitrios, Michael Doumas, Christodoulos Papadopoulos, & Asterios Karagiannis. (2021). Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials. Clinical Rheumatology. 40(11). 4671–4674.
7.
Patoulias, Dimitrios, et al.. (2021). Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology. 166. 144–145.
8.
Patoulias, Dimitrios, Michael Doumas, Vasilios Kotsis, et al.. (2020). Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis. Current Diabetes Reviews. 16(4). 313–326.
9.
Katsiki, Niki, et al.. (2019). Effects of Lipid Lowering Drugs on Arterial Stiffness: One More Way to Reduce Cardiovascular Risk?. Current Vascular Pharmacology. 18(1). 38–42.
10.
Pantelidis, Panteleimon, Athina A. Samara, Michail Sideris, et al.. (2016). Medical students’ satisfaction with the Applied Basic Clinical Seminar with Scenarios for Students, a novel simulation-based learning method in Greece. Journal of Educational Evaluation for Health Professions. 13. 13–13.
11.
Pyrpasopoulou, Athina, Κωνσταντίνα Κοντοπούλου, Konstantinos Kitsios, et al.. (2016). A Rare Case of Disseminated Pyogenic Gonococcal Infection in an Immunocompetent Woman. SHILAP Revista de lepidopterología. 2016. 1–4.
12.
Athyros, Vasilios G., Niki Katsiki, Asterios Karagiannis, & Dimitri P. Mikhailidis. (2015). Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opinion on Pharmacotherapy. 16(10). 1449–1461.
13.
Katsiki, Niki, et al.. (2014). Metabolic Syndrome and Non-Cardiac Vascular Diseases: An Update from Human Studies. Current Pharmaceutical Design. 20(31). 4944–4952.
14.
Koumaras, Charalambos, Theodora Griva, Thomas Gossios, et al.. (2012). Role of Antihypertensive Drugs in Arterial ‘De-Stiffening’ and Central Pulsatile Hemodynamics. American Journal of Cardiovascular Drugs. 12(3). 143–156.
15.
Anagnostis, Panagiotis, Vasilios G. Athyros, Fotini Adamidou, Matilda Florentin, & Asterios Karagiannis. (2010). Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk?. Current Vascular Pharmacology. 8(5). 720–730.
16.
Athyros, Vasilios G., et al.. (2010). Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy. Expert Opinion on Pharmacotherapy. 11(5). 723–730.
17.
Τζιόμαλος, Κωνσταντίνος, et al.. (2008). CORONA, Statins, and Heart Failure: Who Lost the Crown? Response. UCL Discovery (University College London).
18.
Athyros, Vasilios G., Anna I. Kakafika, Athanasios A. Papageorgiou, et al.. (2008). Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. Current Medical Research and Opinion. 24(6). 1593–1599.
19.
Athyros, Vasilios G., Anna I. Kakafika, Athanasios A. Papageorgiou, et al.. (2007). Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients. The Open Cardiovascular Medicine Journal. 1(1). 8–14.
20.
Loutradis, Charalampos, et al.. (1969). The Beneficial Actions of SGLT-2 Inhibitors Beyond the Management of Hyperglycemia. Current Medicinal Chemistry. 26. 1–20.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Κωνσταντίνος Τζιόμαλος Breakdown of academic impact, for papers by Evangelos Liberopoulos Breakdown of academic impact, for papers by Niki Katsiki Breakdown of academic impact, for papers by Hubert Scharnagl Breakdown of academic impact, for papers by Luis E. Simental‐Mendía Breakdown of academic impact, for papers by Chul Woo Ahn Breakdown of academic impact, for papers by Wayne Huey‐Herng Sheu Breakdown of academic impact, for papers by Yoshihiro Kokubo Breakdown of academic impact, for papers by Byung‐Wan Lee Breakdown of academic impact, for papers by Ian F. Godsland